VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G Report for Oruka Therapeutics Inc Common Stock (ORKA)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Oruka Therapeutics Inc Common Stock
Symbol: ORKA
Shares outstanding: 48,488,735 shares
Disclosed Ownership: 2,453,530 shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Filing time: 30 Jan 2026, 14:20:43 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.1%	2,453,530	0	291,185	Ashley Grim	Head of Global Fund Administration